The therapeutic potential of long‐acting β2‐adrenoceptor agonists in allergic inflammation
- 1 February 1992
- journal article
- Published by Wiley in Clinical and Experimental Allergy
- Vol. 22 (2) , 177-181
- https://doi.org/10.1111/j.1365-2222.1992.tb03070.x
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Inhibitory effects of formoterol and terbutaline on the development of late phase skin reactionsClinical and Experimental Allergy, 1992
- Characterization of phospholipase A2 activity in rat RPAR-induced pleurisyInflammation Research, 1991
- Recurrence after first seizureThe Lancet, 1991
- Protection against allergen-induced asthma by salmeterolThe Lancet, 1990
- IntroductionClinical and Experimental Allergy, 1990
- Inhibition of anti‐IgE induced skin responsein normals by formoterol, a new β2‐adrenoceptor agonist, and terbutalineAllergy, 1990
- Interactions between histamine and prostanoids in IgE-dependent, late cutaneous reactions in manJournal of Allergy and Clinical Immunology, 1990
- Treatment of atopic dermatitis with salbutamolClinical and Experimental Dermatology, 1987
- Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: A comparison between budesonide and terbutalineJournal of Allergy and Clinical Immunology, 1985
- Terbutaline modulation of human allergic skin reactionsJournal of Allergy and Clinical Immunology, 1983